株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アフェレーシスの世界市場:製品、処置、用途(プラズマフェレーシス、血小板フェレーシス)、技術、エンドユーザー、地域別 - 2025年までの予測

Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User, Region - Global Forecast to 2025

発行 MarketsandMarkets 商品コード 924388
出版日 ページ情報 英文 260 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.31円で換算しております。
Back to Top
アフェレーシスの世界市場:製品、処置、用途(プラズマフェレーシス、血小板フェレーシス)、技術、エンドユーザー、地域別 - 2025年までの予測 Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User, Region - Global Forecast to 2025
出版日: 2020年02月04日 ページ情報: 英文 260 Pages
概要

世界のアフェレーシス市場は2019年の17億米ドルからCAGR8.1%で拡大し、2025年までに27億米ドルに達すると予測されています。同市場は、慢性疾患の罹患率上昇、外傷症例数の増加、バイオ医薬品企業からのプラズマ需要の増加、血液製剤需要、血液の安全性に対する懸念などにより成長が促進されています。

当レポートでは、世界のアフェレーシス市場について調査し、セグメント別動向、2025年までの成長予測、地域別動向、および市場に参入する企業のプロファイルなどについてまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • 市場動向:影響分析
    • 促進因子
    • 阻害因子
    • 機会
    • 課題

第6章 業界動向

  • 業界動向
  • ポーターズファイブソース分析
  • 法規制分析

第7章 アフェレーシス市場:製品別

  • イントロダクション
  • ディスポーザブル
  • 装置
    • 遠心分離
    • 膜分離

第8章 アフェレーシス市場:処置別

  • イントロダクション
  • 自動採血(ドナーアフェレーシス)
  • 治療用アフェレーシス

第9章 アフェレーシス市場:技術別

  • イントロダクション
  • 遠心分離
  • 膜分離

第10章 アフェレーシス市場:用途別

  • イントロダクション
  • プラズマフェレーシス
  • 血小板フェレーシス
  • 赤血球アフェレーシス
  • 白血球アフェレーシス
  • フォトアフェレーシス
  • その他

第11章 アフェレーシス市場:エンドユーザー別

  • イントロダクション
  • 採血センター、血液製剤プロバイダー
  • 病院、輸血センター
  • その他

第12章 アフェレーシス市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第13章 競合環境

  • 概要
  • 市場シェア分析
  • 競合リーダーシップマッピング
  • 競合動向

第14章 企業プロファイル

第15章 付録

図表

LIST OF TABLES

  • TABLE 1 REQUIRED UNITS OF BLOOD AND BLOOD COMPONENTS, BY TYPE OF SURGERY
  • TABLE 2 US: PAYMENT RATES FOR APHERESIS PROCEDURES, 2016-2018
  • TABLE 3 ESTIMATED BLOOD DONATIONS BY WHO REGION, 2013
  • TABLE 4 FREQUENCY OF BLOOD DONATIONS FROM HEALTHY DONORS
  • TABLE 5 APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 6 APHERESIS DISPOSABLES MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 7 APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 8 APHERESIS DEVICES MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 9 LIST OF CENTRIFUGAL APHERESIS DEVICES AVAILABLE IN THE MARKET
  • TABLE 10 CENTRIFUGAL APHERESIS DEVICES MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 11 LIST OF MEMBRANE SEPARATORS AVAILABLE IN THE MARKET
  • TABLE 12 MEMBRANE SEPARATORS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 13 APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 14 APHERESIS DEVICES USED FOR AUTOMATED BLOOD COLLECTION PROCEDURES
  • TABLE 15 AUTOMATED BLOOD COLLECTION (DONOR APHERESIS) MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 16 THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 17 THERAPEUTIC APHERESIS MARKET BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 18 THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 19 THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 20 NEUROLOGICAL DISORDERS TREATED USING THERAPEUTIC APHERESIS
  • TABLE 21 NEUROLOGICAL DISORDERS: ESTIMATED DALYS, BY REGION, 2015 VS. 2030
  • TABLE 22 THERAPEUTIC APHERESIS DISPOSABLES MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 23 THERAPEUTIC APHERESIS DISPOSABLES MARKET FOR BLOOD DISORDERS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 24 THERAPEUTIC APHERESIS DISPOSABLES MARKET FOR RENAL DISORDERS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 25 THERAPEUTIC APHERESIS DISPOSABLES MARKET FOR AUTOIMMUNE DISORDERS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 26 METABOLIC DISORDERS: ESTIMATED DALYS BY REGION, 2015 VS. 2030 (THOUSANDS)
  • TABLE 27 THERAPEUTIC APHERESIS DISPOSABLES MARKET FOR METABOLIC DISORDERS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 28 CARDIOVASCULAR DISORDERS: ESTIMATED DALYS BY REGION, 2015 VS. 2030 (THOUSANDS)
  • TABLE 29 THERAPEUTIC APHERESIS DISPOSABLES MARKET FOR CARDIOVASCULAR DISORDERS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 30 THERAPEUTIC APHERESIS DISPOSABLES MARKET FOR OTHER DISORDERS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 31 KEY PRODUCTS AVAILABLE IN THE MARKET FOR THERAPEUTIC APHERESIS
  • TABLE 32 THERAPEUTIC APHERESIS DEVICES MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 33 CENTRIFUGATION VS. MEMBRANE SEPARATION
  • TABLE 34 APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 35 CONTINUOUS FLOW CENTRIFUGATION VS. INTERMITTENT FLOW CENTRIFUGATION
  • TABLE 36 CENTRIFUGATION MARKET: KEY PLAYERS AND PRODUCTS
  • TABLE 37 CENTRIFUGATION MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 38 CENTRIFUGATION MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 39 CONTINUOUS FLOW CENTRIFUGATION MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 40 INTERMITTENT FLOW CENTRIFUGATION MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 41 SIZE OF BLOOD COMPONENTS
  • TABLE 42 MEMBRANE SEPARATION MARKET: KEY PLAYERS AND PRODUCTS
  • TABLE 43 MEMBRANE SEPARATION MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 44 APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 45 TOTAL SOURCE PLASMA COLLECTION IN THE US & EUROPE, 2007-2017 (MILLION LITERS)
  • TABLE 46 KEY PRODUCTS AVAILABLE FOR PLASMAPHERESIS AND THERAPEUTIC PLASMA EXCHANGE
  • TABLE 47 APHERESIS MARKET FOR PLASMAPHERESIS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 48 KEY PRODUCTS AVAILABLE FOR PLATELETPHERESIS
  • TABLE 49 APHERESIS MARKET FOR PLATELETPHERESIS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 50 KEY PRODUCTS AVAILABLE FOR ERYTHROCYTAPHERESIS
  • TABLE 51 APHERESIS MARKET FOR ERYTHROCYTAPHERESIS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 52 KEY PRODUCTS AVAILABLE FOR LEUKAPHERESIS
  • TABLE 53 APHERESIS MARKET FOR LEUKAPHERESIS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 54 KEY PRODUCTS AVAILABLE FOR PHOTOPHERESIS
  • TABLE 55 APHERESIS MARKET FOR PHOTOPHERESIS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 56 KEY PRODUCTS AVAILABLE FOR OTHER APPLICATIONS OF APHERESIS
  • TABLE 57 APHERESIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 58 APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 59 APHERESIS MARKET FOR BLOOD COLLECTION CENTERS AND BLOOD COMPONENT PROVIDERS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 60 NUMBER OF HOSPITALS PERFORMING BLOOD TRANSFUSIONS, BY REGION, 2015
  • TABLE 61 APHERESIS MARKET FOR HOSPITALS AND TRANSFUSION CENTERS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 62 APHERESIS MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 63 APHERESIS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 64 NORTH AMERICA: HEMOPHILIA PATIENTS, 2013 VS. 2017
  • TABLE 65 NORTH AMERICA: APHERESIS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 66 NORTH AMERICA: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 67 NORTH AMERICA: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 68 NORTH AMERICA: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 69 NORTH AMERICA: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 70 NORTH AMERICA: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 71 NORTH AMERICA: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 72 NORTH AMERICA: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 73 NORTH AMERICA: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 74 NORTH AMERICA: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 75 US: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 76 US: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 77 US: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 78 US: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 79 US: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 80 US: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 81 US: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 82 US: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 83 US: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 84 US: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 85 CANADA: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 86 CANADA: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 87 CANADA: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 88 CANADA: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 89 CANADA: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 90 CANADA: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 91 CANADA: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 92 CANADA: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 93 CANADA: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 94 CANADA: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 95 COLLECTIONS OF BLOOD COMPONENTS USING APHERESIS ACROSS EUROPEAN COUNTRIES IN 2013
  • TABLE 96 EUROPE: APHERESIS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 97 EUROPE: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 98 EUROPE: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 99 EUROPE: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 100 EUROPE: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 101 EUROPE: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPES, 2017-2025 (USD MILLION)
  • TABLE 102 EUROPE: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 103 EUROPE: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 104 EUROPE: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 105 EUROPE: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 106 INCREASING HEALTHCARE EXPENDITURE IN GERMANY, 2015-2017 (USD MILLION)
  • TABLE 107 GERMANY: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 108 GERMANY: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 109 GERMANY: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 110 GERMANY: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 111 GERMANY: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 112 GERMANY: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 113 GERMANY: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 114 GERMANY: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 115 GERMANY: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 116 GERMANY: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 117 FRANCE: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 118 FRANCE: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 119 FRANCE: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 120 FRANCE: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 121 FRANCE: THERAPEUTIC APHERESIS MARKET, BY PRODUCT 2017-2025 (USD MILLION)
  • TABLE 122 FRANCE: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 123 FRANCE: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 124 FRANCE: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 125 FRANCE: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 126 FRANCE: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 127 ITALY: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 128 ITALY: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 129 ITALY: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 130 ITALY: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 131 ITALY: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 132 ITALY: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 133 ITALY: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 134 ITALY: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 135 ITALY: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 136 ITALY: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 137 UK: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 138 UK: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 139 UK: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 140 UK: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 141 UK: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 142 UK: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 143 UK: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 144 UK: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 145 UK: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 146 UK: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 147 SPAIN: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 148 SPAIN: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 149 SPAIN: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 150 SPAIN: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 151 SPAIN: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 152 SPAIN: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 153 SPAIN: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 154 SPAIN: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 155 SPAIN: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 156 SPAIN: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 157 ROE: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 158 ROE: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 159 ROE: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 160 ROE: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 161 ROE: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 162 ROE: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 163 ROE: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 164 ROE: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 165 ROE: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: APHERESIS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 176 CHINA: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 177 CHINA: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 178 CHINA: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 179 CHINA: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 180 CHINA: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 181 CHINA: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 182 CHINA: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 183 CHINA: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 184 CHINA: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 185 CHINA: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 186 BLOOD DONATIONS IN JAPAN, BY TYPE OF DONATION, 2015
  • TABLE 187 JAPAN: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 188 JAPAN: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 189 JAPAN: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 190 JAPAN: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 191 JAPAN: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 192 JAPAN: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 193 JAPAN: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 194 JAPAN: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 195 JAPAN: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 196 JAPAN: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 197 INDIA: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 198 INDIA: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 199 INDIA: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 200 INDIA: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 201 INDIA: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 202 INDIA: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 203 INDIA: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 204 INDIA: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 205 INDIA: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 206 INDIA: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 207 ROAPAC: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 208 ROAPAC: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 209 ROAPAC: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 210 ROAPAC: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 211 ROAPAC: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 212 ROAPAC: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 213 ROAPAC: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 214 ROAPAC: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 215 ROAPAC: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 216 LATIN AMERICA: APHERESIS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 217 LATIN AMERICA: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 218 LATIN AMERICA: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 219 LATIN AMERICA: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 220 LATIN AMERICA: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 221 LATIN AMERICA: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 222 LATIN AMERICA: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 223 LATIN AMERICA: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 224 LATIN AMERICA: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 225 LATIN AMERICA: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 226 BRAZIL: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 227 BRAZIL: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 228 BRAZIL: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 229 BRAZIL: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 230 BRAZIL: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 231 BRAZIL: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 232 BRAZIL: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 233 BRAZIL: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 234 BRAZIL: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 235 BRAZIL: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 236 MEXICO: KEY MACROINDICATORS FOR THE APHERESIS MARKET
  • TABLE 237 MEXICO: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 238 MEXICO: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 239 MEXICO: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 240 MEXICO: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 241 MEXICO: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 242 MEXICO: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 243 MEXICO: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 244 MEXICO: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 245 MEXICO: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 246 ROLA: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 247 ROLA: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 248 ROLA: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 249 ROLA: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 250 ROLA: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 251 ROLA: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 252 ROLA: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 253 ROLA: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 254 ROLA: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 255 MEA: APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 256 MEA: APHERESIS DEVICES MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 257 MEA: APHERESIS MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)
  • TABLE 258 MEA: THERAPEUTIC APHERESIS MARKET, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 259 MEA: THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2017-2025 (USD MILLION)
  • TABLE 260 MEA: APHERESIS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 261 MEA: CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 262 MEA: APHERESIS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 263 MEA: APHERESIS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 264 PRODUCT LAUNCHES & APPROVALS (2017-2019)
  • TABLE 265 EXPANSIONS (2017-2019)
  • TABLE 266 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017-2019)
  • TABLE 267 ACQUISITIONS (2017)
  • TABLE 268 OTHER STRATEGIES (2018-2019)

LIST OF FIGURES

  • FIGURE 1 APHERESIS MARKET
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BOTTOM-UP APPROACH
  • FIGURE 5 TOP-UP APPROACH
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • FIGURE 7 APHERESIS MARKET, BY PRODUCT, 2019 VS. 2025 (USD MILLION)
  • FIGURE 8 APHERESIS DEVICES MARKET, BY TYPE, 2019 VS. 2025 (USD MILLION)
  • FIGURE 9 APHERESIS MARKET, BY PROCEDURE, 2019 VS. 2025 (USD MILLION)
  • FIGURE 10 THERAPEUTIC APHERESIS PROCEDURES MARKET, BY PRODUCT, 2019 VS. 2025 (USD MILLION)
  • FIGURE 11 THERAPEUTIC APHERESIS DISPOSABLES MARKET, BY DISEASE TYPE, 2019 VS. 2025 (USD MILLION)
  • FIGURE 12 APHERESIS MARKET, BY TECHNOLOGY, 2019 VS. 2025 (USD MILLION)
  • FIGURE 13 CENTRIFUGATION APHERESIS MARKET, BY TYPE, 2019 VS. 2025 (USD MILLION)
  • FIGURE 14 APHERESIS MARKET, BY APPLICATION, 2019 VS. 2025 (USD MILLION)
  • FIGURE 15 APHERESIS MARKET, BY END USER, 2019 VS. 2025 (USD MILLION)
  • FIGURE 16 GEOGRAPHIC SNAPSHOT: APHERESIS MARKET
  • FIGURE 17 RISING PREVALENCE OF DISEASES AND THE GROWING NUMBER OF TRAUMA AND INJURY CASES TO DRIVE MARKET GROWTH
  • FIGURE 18 PLASMAPHERESIS ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN APHERESIS MARKET IN 2018
  • FIGURE 19 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2018
  • FIGURE 20 APAC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 22 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN THE US, 1995-2030 (MILLION INDIVIDUALS)
  • FIGURE 23 TYPE OF PLASMA PROCESSED WORLDWIDE, 1990-2014 (MILLION LITERS)
  • FIGURE 24 PORTER'S FIVE FORCES ANALYSIS (2018): APHERESIS MARKET
  • FIGURE 25 APHERESIS DISPOSABLES TO DOMINATE THE APHERESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 26 AUTOMATED BLOOD COLLECTION ACCOUNTED FOR THE LARGEST SHARE OF THE APHERESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 27 THERAPEUTIC APHERESIS DISPOSABLES TO DOMINATE THE THERAPEUTIC APHERESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 28 NEUROLOGICAL DISORDERS TO ACCOUNT FOR THE LARGEST SHARE OF THE THERAPEUTIC APHERESIS DISPOSABLES MARKET DURING THE FORECAST PERIOD
  • FIGURE 29 CENTRIFUGATION SEGMENT TO DOMINATE THE APHERESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 30 BLOOD COLLECTION CENTERS AND BLOOD COMPONENT PROVIDERS SEGMENT TO DOMINATE THE APHERESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 31 APHERESIS MARKET: GEOGRAPHIC SNAPSHOT (2018)
  • FIGURE 32 NORTH AMERICA: APHERESIS MARKET SNAPSHOT
  • FIGURE 33 EUROPE: APHERESIS MARKET SNAPSHOT
  • FIGURE 34 ASIA PACIFIC: APHERESIS MARKET SNAPSHOT
  • FIGURE 35 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2017 TO 2019
  • FIGURE 36 GLOBAL APHERESIS MARKET SHARE, BY KEY PLAYER, 2018
  • FIGURE 37 GLOBAL CENTRIFUGATION MARKET SHARE, BY KEY PLAYER, 2018
  • FIGURE 38 GLOBAL MEMBRANE SEPARATION MARKET SHARE, BY KEY PLAYER, 2018
  • FIGURE 39 APHERESIS MARKET: COMPETITIVE LEADERSHIP MAPPING (2018)
  • FIGURE 40 TERUMO BCT, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 41 FRESENIUS MEDICAL CARE: COMPANY SNAPSHOT (2018)
  • FIGURE 42 FRESENIUS KABI: COMPANY SNAPSHOT (2018)
  • FIGURE 43 HAEMONETICS CORPORATION: COMPANY SNAPSHOT (2019)
  • FIGURE 44 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2018)
  • FIGURE 45 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 46 B. BRAUN: COMPANY SNAPSHOT (2018)
  • FIGURE 47 CERUS CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 48 KANEKA CORPORATION: COMPANY SNAPSHOT (2019)
  • FIGURE 49 KAWASUMI LABORATORIES: COMPANY SNAPSHOT (2019)
  • FIGURE 50 NIKKISO CO., LTD.: COMPANY SNAPSHOT (2018)
  • FIGURE 51 OTSUKA HOLDINGS COMPANY LIMITED: COMPANY SNAPSHOT (2018)
  • FIGURE 52 MALLINCKRODT PLC : COMPANY SNAPSHOT (2018)
  • FIGURE 53 CYTOSORBENTS CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 54 TORAY MEDICAL CO. LTD.: COMPANY SNAPSHOT (2019)
目次
Product Code: MD 1407

"The apheresis market is projected to grow at a CAGR of 8.1%."

The global apheresis market is projected to reach USD 2.7 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 8.1% during the forecast period. The market for apheresis is primarily driven by the rising prevalence of chronic diseases and the growing number of trauma and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.

"In 2018, the apheresis disposables segment accounted for the largest share of the market."

On the basis of product, the apheresis disposables segment accounted for the largest share of the apheresis market in 2018. The large share of this segment can be attributed to its recurrent use, increasing blood donations using apheresis devices, increasing number of therapeutic apheresis procedures, and favorable reimbursement policies for apheresis procedures.

"In 2018, the Automated Blood Collection (Donor Apheresis) segment accounted for the largest share of the market."

On the basis of procedure, the automated blood collection (donor apheresis) segment accounted for the largest share of the apheresis market in 2018. The large share of this segment can be attributed to the increasing number of blood component donations using apheresis devices and the increasing demand for source plasma from biopharmaceutical companies.

"In 2018, the centrifugation segment accounted for the largest share of the market."

On the basis of technology, the centrifugation segment accounted for the largest share of the apheresis market in 2018. The large share of this segment can be attributed to the advantages offered by centrifugation over membrane separation, such as its high efficiency and its ability to separate all types of blood components.

"In 2018, the plasmapheresis segment accounted for the largest share of the market."

On the basis of application, the plasmapheresis segment accounted for the largest share of the apheresis market in 2018. The large share of this segment can be attributed to the increasing demand for plasma from biopharmaceutical companies and the use of plasmapheresis as a key therapeutic apheresis procedure.

"In 2018, the blood collection centers and blood component providers segment accounted for the largest share of the market."

On the basis of end user, the blood collection centers and blood component providers segment accounted for the largest share of the apheresis market in 2018. The large share of this segment is mainly attributed to the rising number of blood component donations, a growing number of blood centers, and increasing awareness.

"APAC is projected to witness the highest growth during the forecast period."

The APAC market is estimated to register the highest CAGR during the forecast period. The growth in this market can be attributed to the rapid growth in geriatric population, improving healthcare infrastructure, increasing per capita income of the middle-class population in the region, rising focus of key market players on emerging APAC countries, and the increasing accessibility to a range of products with leading players entering these lucrative geographical regions.

The breakdown of primary participants was as mentioned below:

  • By Company Type: Tier 1-45%, Tier 2-30%, and Tier 3-25%
  • By Designation: C-level-35%, Director Level-25%, and Others-40%
  • By Region: North America-40%, Europe-20%, Asia Pacific-25%, Latin America-10%, Middle East & Africa-5%

The leading players in this market include: Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), and Nikkiso Co., Ltd. (Japan).

Research Coverage:

The report analyzes the various apheresis devices and their adoption patterns. It aims at estimating the market size and future growth potential of the apheresis market for different segments such as product, technology, procedure, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the apheresis market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the apheresis market
  • Market Development: Comprehensive information on the lucrative emerging regions by product, technology, procedure, application, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the apheresis market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the apheresis market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION AND SCOPE
    • 1.2.1 MARKETS COVERED
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 DATA TRIANGULATION APPROACH
  • 2.4 MARKET SHARE ESTIMATION
    • 2.4.1 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 APHERESIS MARKET OVERVIEW
  • 4.2 EUROPE: APHERESIS MARKET, BY APPLICATION
  • 4.3 GEOGRAPHIC SNAPSHOT OF THE APHERESIS MARKET (2018)
  • 4.4 GEOGRAPHIC MIX: APHERESIS MARKET, 2019-2025 (USD MILLION)
  • 4.5 APHERESIS MARKET: DEVELOPING VS. DEVELOPED MARKETS, 2019 VS. 2025 (USD MILLION)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of chronic diseases and growing number of trauma and injury cases
      • 5.2.1.2 Increasing demand for source plasma from biopharmaceutical companies
      • 5.2.1.3 Rising demand for blood components and growing concerns regarding blood safety
      • 5.2.1.4 Increase in the number of complex surgical procedures
      • 5.2.1.5 Favorable reimbursement for apheresis procedures
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of apheresis devices & therapeutic apheresis procedures and installation of apheresis devices through rental model
      • 5.2.2.2 Fewer blood donations using apheresis due to lack of awareness
      • 5.2.2.3 Stringent donor recruitment criteria
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Apheresis for leukemia and pediatric patients
      • 5.2.3.2 Emerging economies with increasing investments from government bodies and leading players
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Recruitment of voluntary non-remunerated donors
      • 5.2.4.2 Safety of blood transfusion in developing countries

6 INDUSTRY INSIGHTS

  • 6.1 INDUSTRY TRENDS
    • 6.1.1 NEW INDICATIONS FOR PLASMA PRODUCTS
    • 6.1.2 INCREASING NUMBER OF COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
  • 6.2 PORTER'S FIVE FORCE ANALYSIS
    • 6.2.1 THREAT FROM NEW ENTRANTS
    • 6.2.2 THREAT FROM SUBSTITUTES
    • 6.2.3 BARGAINING POWER OF SUPPLIERS
    • 6.2.4 BARGAINING POWER OF BUYERS
    • 6.2.5 INTENSITY OF COMPETITIVE RIVALRY
  • 6.3 REGULATORY ANALYSIS
    • 6.3.1 NORTH AMERICA
      • 6.3.1.1 US
      • 6.3.1.2 Canada
    • 6.3.2 EUROPE
    • 6.3.3 ASIA PACIFIC
      • 6.3.3.1 Japan
      • 6.3.3.2 China
      • 6.3.3.3 India

7 APHERESIS MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
  • 7.2 APHERESIS DISPOSABLES
    • 7.2.1 RECURRENT USE OF APHERESIS DISPOSABLES TO DRIVE GROWTH IN THIS MARKET SEGMENT
  • 7.3 APHERESIS DEVICES
    • 7.3.1 CENTRIFUGAL APHERESIS DEVICES
      • 7.3.1.1 Increasing installation of centrifugal apheresis devices in hospitals for therapeutic apheresis drives market growth
    • 7.3.2 MEMBRANE SEPARATORS
      • 7.3.2.1 Difficulties in separating huge volumes of plasma from milliliters of whole blood-a key factor limiting the adoption of these devices

8 APHERESIS MARKET, BY PROCEDURE

  • 8.1 INTRODUCTION
  • 8.2 AUTOMATED BLOOD COLLECTION (DONOR APHERESIS)
    • 8.2.1 INCREASING NUMBER OF BLOOD COMPONENT DONATIONS USING APHERESIS DEVICES TO SUPPORT MARKET GROWTH
  • 8.3 THERAPEUTIC APHERESIS
    • 8.3.1 THERAPEUTIC APHERESIS DISPOSABLES
      • 8.3.1.1 Neurological disorders
        • 8.3.1.1.1 Neurological disorders hold a major share in the therapeutic apheresis disposables market
      • 8.3.1.2 Blood disorders
        • 8.3.1.2.1 Increasing prevalence and incidence of hematologic and genetic disorders will boost the demand for therapeutic apheresis disposables
      • 8.3.1.3 Renal disorders
        • 8.3.1.3.1 Therapeutic plasma exchange is regarded as one of the most useful treatment options for several renal disorders
      • 8.3.1.4 Autoimmune disorders
        • 8.3.1.4.1 With the introduction of novel and effective biologic agents for the treatment of various autoimmune disorders, therapeutic apheresis is indicated only in severe cases
      • 8.3.1.5 Metabolic disorders
        • 8.3.1.5.1 Increasing adoption of plasmapheresis for the treatment of diabetes and other metabolic disorders drives the growth of this segment
      • 8.3.1.6 Cardiovascular disorders
        • 8.3.1.6.1 Low-density lipoprotein (LDL) apheresis is mainly used in the treatment of cardiovascular disorders
      • 8.3.1.7 Other disorders
    • 8.3.2 THERAPEUTIC APHERESIS DEVICES
      • 8.3.2.1 Centrifugation-based devices are one of the most commonly adopted therapeutic apheresis devices

9 APHERESIS MARKET, BY TECHNOLOGY

  • 9.1 INTRODUCTION
  • 9.2 CENTRIFUGATION
    • 9.2.1 CONTINUOUS FLOW CENTRIFUGATION
      • 9.2.1.1 Continuous flow is preferred in both blood collection and therapeutic apheresis procedures
    • 9.2.2 INTERMITTENT FLOW CENTRIFUGATION
      • 9.2.2.1 The need for a single venipuncture site is a major factor driving the demand for intermittent flow centrifugation
  • 9.3 MEMBRANE SEPARATION
    • 9.3.1 HIGHER EFFICACY OF THIS TECHNOLOGY ACCOUNTS FOR ITS HIGH USAGE IN DEVELOPED WESTERN EUROPEAN COUNTRIES AND JAPAN

10 APHERESIS MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
  • 10.2 PLASMAPHERESIS
    • 10.2.1 PLASMAPHERESIS IS THE LARGEST APPLICATION SEGMENT IN THE APHERESIS MARKET
  • 10.3 PLATELETPHERESIS
    • 10.3.1 INCREASING DEMAND FOR PLATELETS IN TRANSFUSIONS TO DRIVE MARKET GROWTH
  • 10.4 ERYTHROCYTAPHERESIS
    • 10.4.1 INCREASING DEMAND FOR RED BLOOD CELLS FOR TRANSFUSION IN SURGICAL PROCEDURES TO DRIVE MARKET GROWTH
  • 10.5 LEUKAPHERESIS
    • 10.5.1 INCREASING INCIDENCE AND PREVALENCE OF LEUKEMIA TO DRIVE THE LEUKAPHERESIS MARKET
  • 10.6 PHOTOPHERESIS
    • 10.6.1 PHOTOPHERESIS IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 10.7 OTHER APPLICATIONS

11 APHERESIS MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS
    • 11.2.1 BLOOD COLLECTION CENTERS AND BLOOD COMPONENT PROVIDERS HOLD A MAJOR SHARE OF THE APHERESIS MARKET
  • 11.3 HOSPITALS AND TRANSFUSION CENTERS
    • 11.3.1 HOSPITALS AND TRANSFUSION CENTERS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 11.4 OTHER END USERS

12 APHERESIS MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 US
      • 12.2.1.1 The US dominates the North American apheresis market
    • 12.2.2 CANADA
      • 12.2.2.1 The demand for plasma protein products in Canada is on the rise, which is a key factor driving market growth
  • 12.3 EUROPE
    • 12.3.1 GERMANY
      • 12.3.1.1 Germany is the fastest-growing market for apheresis in Europe
    • 12.3.2 FRANCE
      • 12.3.2.1 Increasing need for blood components to drive the market for apheresis in France
    • 12.3.3 ITALY
      • 12.3.3.1 Therapeutic plasma exchange and LDL apheresis are widely adopted therapeutic apheresis procedures, thereby driving market growth in Italy
    • 12.3.4 UK
      • 12.3.4.1 Increasing demand for source plasma to cater to the growing consumption of plasma-derived products (IVIG) driving apheresis market growth in the UK
    • 12.3.5 SPAIN
      • 12.3.5.1 Growing demand for blood components and plasma-derived products for the treatment of chronic diseases in the elderly is a key factor driving market growth in Spain
    • 12.3.6 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 CHINA
      • 12.4.1.1 China accounts for the largest share of the APAC apheresis market
    • 12.4.2 JAPAN
      • 12.4.2.1 Increasing demand for technologically advanced products drives the market growth in Japan
    • 12.4.3 INDIA
      • 12.4.3.1 In India, the increasing demand for blood components and growing applications of plasma derivatives are major factors driving the growth of the apheresis market
    • 12.4.4 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 BRAZIL
      • 12.5.1.1 Brazil offers lucrative growth opportunities in the apheresis market due to an increasing number of blood and plasma donations
    • 12.5.2 MEXICO
      • 12.5.2.1 Rapidly growing geriatric population is a key factor driving market growth in Mexico
    • 12.5.3 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 MARKET SHARE ANALYSIS
    • 13.2.1 GLOBAL APHERESIS MARKET SHARE ANALYSIS
    • 13.2.2 GLOBAL CENTRIFUGATION MARKET SHARE ANALYSIS
    • 13.2.3 GLOBAL MEMBRANE SEPARATION MARKET SHARE ANALYSIS
  • 13.3 COMPETITIVE LEADERSHIP MAPPING
    • 13.3.1 VISIONARY LEADERS
    • 13.3.2 INNOVATORS
    • 13.3.3 DYNAMIC DIFFERENTIATORS
    • 13.3.4 EMERGING COMPANIES
  • 13.4 COMPETITIVE SITUATION AND TRENDS
    • 13.4.1 PRODUCT LAUNCHES & APPROVALS
    • 13.4.2 EXPANSIONS
    • 13.4.3 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 13.4.4 ACQUISITIONS

14 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, Strategic overview, CompEtitive analysis)*

  • 14.1 TERUMO BCT, INC.
  • 14.2 FRESENIUS SE & CO. KGAA
  • 14.3 HAEMONETICS CORPORATION
  • 14.4 BAXTER INTERNATIONAL INC.
  • 14.5 ASAHI KASEI MEDICAL CO. LTD. (A SUBSIDIARY OF ASAHI KASEI CORPORATION)
  • 14.6 B. BRAUN MELSUNGEN AG
  • 14.7 CERUS CORPORATION
  • 14.8 KANEKA CORPORATION
  • 14.9 KAWASUMI LABORATORIES, INC.
  • 14.10 NIKKISO CO., LTD.
  • 14.11 MACOPHARMA SA
  • 14.12 MILTENYI BIOTEC
  • 14.13 OTSUKA HOLDINGS CO., LTD.
  • 14.14 MEDICA SPA
  • 14.15 MALLINCKRODT PLC
  • 14.16 MEDICAP CLINIC GMBH
  • 14.17 LMB TECHNOLOGIE GMBH
  • 14.18 BIOELETTRONICA SRL
  • 14.19 INFOMED
  • 14.20 CYTOSORBENTS CORPORATION
  • 14.21 TORAY MEDICAL CO., LTD.

Details on Business Overview, Products Offered, Recent Developments, Strategic overview, CompEtitive analysis might not be captured in case of unlisted companies.

15 APPENDIX

  • 15.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 15.2 DISCUSSION GUIDE
  • 15.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.4 AVAILABLE CUSTOMIZATIONS
  • 15.5 RELATED REPORTS
  • 15.6 AUTHOR DETAILS
Back to Top